Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL — Stella

Recruiting

Back to DLBCL - Diffuse Large B Cell Lymphoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Bing Xu, Xiamen, Fujian

Key details

Phase

Safety & dosing

Sponsor

The First Affiliated Hospital of Xiamen University

Collaborators

The First Affiliated Hospital with Nanjing Medical University, Sun Yat-sen University

Enrollment target

~38 participants

Started

November 2023

Primary completion

August 2027

Age range

18 Years – 70 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov